GlassScriptPhysician profile
Ishwara Sharma
NPI 1912960741
$18,454.40
in general payments reported to CMS, 2019-2025
52 companies · $3,189 in 2025
The $3,189 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,115 · 2020: $1,837 · 2021: $2,353 · 2022: $3,452 · 2023: $3,640 · 2024: $2,868 · 2025: $3,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,677 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,677.00 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,696.66 | 2019-2025 | Farxiga, Airsupra, Tagrisso |
| Abbvie INC. | $2,209.72 | 2021-2025 | Linzess, Qulipta, Viberzi |
| Amgen INC. | $1,513.05 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $1,503.78 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $1,186.85 | 2019-2025 | |
| Novo Nordisk INC | $1,081.00 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $948.26 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $899.68 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $563.93 | 2019-2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $563.32 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $537.48 | 2020-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $427.51 | 2021-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $382.55 | 2019-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $330.78 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $306.81 | 2023-2025 | Gemtesa |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $303.61 | 2024-2025 | Onpattro, Amvuttra |
| Glaxosmithkline, LLC. | $302.39 | 2019-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $280.99 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $257.56 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $232.98 | 2019-2024 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $230.88 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $184.54 | 2024-2025 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $169.76 | 2022 | |
| Dexcom, INC. | $141.86 | 2022-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Inspire Medical Systems, INC. | $141.19 | 2024-2025 | Inspire |
| Esperion Therapeutics, INC. | $131.57 | 2021-2025 | Nexletol |
| Ardelyx, INC. | $122.26 | 2024-2025 | Ibsrela |
| Kowa Pharmaceuticals America, INC. | $119.35 | 2020-2025 | Zoryve |
| Antares Pharma, INC. | $69.08 | 2023 | Xyosted, Nocdurna, Tlando |
| Lexicon Pharmaceuticals, INC. | $66.90 | 2023 | Inpefa |
| Medtronic, INC. | $63.82 | 2023-2025 | Intellis Adaptivestim, Venaseal |
| Sunovion Pharmaceuticals INC. | $53.55 | 2022 | |
| Idorsia Pharmaceuticals US INC | $45.48 | 2023 | Quviviq |
| Bardy Diagnostics, INC. | $40.00 | 2020 | |
| Vanda Pharmaceuticals INC. | $27.00 | 2025 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $25.31 | 2023 | Rexulti |
| Madrigal Pharmaceuticals | $24.23 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $22.72 | 2021 | |
| Recordati_rare_diseases_inc. | $22.54 | 2025 | Isturisa |
| Mylan Specialty L.P. | $21.87 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $20.27 | 2019 | |
| Scpharmaceuticals INC. | $20.23 | 2025 | |
| Urovant Sciences INC | $19.47 | 2022 | |
| Redhill Biopharma INC. | $19.31 | 2020 | |
| Verona Pharma, INC. | $19.29 | 2025 | Ohtuvayre |
| Allergan, INC. | $18.82 | 2020 | |
| Genentech USA, INC. | $15.78 | 2020 | |
| Boston Scientific Corporation | $14.67 | 2024 | Watchman Flx |
| Paratek Pharmaceuticals, INC. | $14.60 | 2024 | Nuzyra |
| Philips North America LLC | $14.31 | 2024 | (5050) Extended Holter |
| Altathera Pharmaceuticals LLC | $13.01 | 2025 | Sotalol Hydrochloride |
| Teva Pharmaceuticals USA, INC. | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ishwara Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.